Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023

SELL
$84.9 - $102.89 $424 - $514
-5 Reduced 21.74%
18 $2,000
Q2 2022

Aug 04, 2022

BUY
$87.94 - $101.67 $263 - $305
3 Added 15.0%
23 $2,000
Q1 2022

May 03, 2022

BUY
$85.56 - $107.12 $1,112 - $1,392
13 Added 185.71%
20 $2,000
Q4 2021

Feb 10, 2022

SELL
$97.41 - $116.74 $97 - $116
-1 Reduced 12.5%
7 $1,000
Q1 2021

May 28, 2021

BUY
$95.11 - $111.11 $760 - $888
8 New
8 $0

Others Institutions Holding CSLLY

About CSL LTD


  • Ticker CSLLY
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 964,432,000
  • Market Cap $84.7B
  • Description
  • CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plas...
More about CSLLY
Track This Portfolio

Track Sierra Capital LLC Portfolio

Follow Sierra Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sierra Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sierra Capital LLC with notifications on news.